Acer Medical Inc. (TPEX:6857)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
100.00
0.00 (0.00%)
Feb 11, 2026, 11:53 AM CST
Market Cap1.52B -34.6%
Revenue (ttm)55.10M +21.6%
Net Income-30.32M
EPS-1.99
Shares Out15.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100
Average Volume1,562
Open100.00
Previous Close100.00
Day's Range100.00 - 100.00
52-Week Range97.00 - 192.00
Beta0.97
RSI39.16
Earnings DateApr 17, 2026

About Acer Medical

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. It offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan. [Read more]

Sector Healthcare
Founded 2018
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6857
Full Company Profile

Financial Performance

In 2024, Acer Medical's revenue was 50.16 million, an increase of 82.73% compared to the previous year's 27.45 million. Losses were -27.36 million, -28.33% less than in 2023.

Financial Statements